Related Experiment Video
Updated: Jun 10, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
Published on: May 26, 2022
[Recent clinical trials in hypertensiology]
Ewelina Kurlapska1, Jan Henryk Goch, Krzysztof Kasprzak
1Wojskowy Szpital Kliniczny z Poliklinika w Bydgoszczy, Klinika Kardiologii i Kardiochirurgii. kardiologia@10wsk.mil.pl
Angiotensin converting enzyme inhibitors and/or angiotensin receptor antagonists are effective for hypertension control, reducing complications. Antihypertensive therapy in the elderly lowers cardiovascular morbidity and mortality.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Hypertension management is a critical area of cardiovascular medicine.
- Recent large randomized clinical trials have provided new insights into antihypertensive drug efficacy.
Purpose:
- To evaluate the efficacy and safety of various antihypertensive drug classes.
- To compare the effectiveness of different treatment strategies in controlling blood pressure and preventing complications.
Summary:
- Angiotensin converting enzyme inhibitors (ACEIs) and/or angiotensin receptor antagonists (ARBs), particularly in combination with calcium antagonists, demonstrate superior blood pressure control and complication reduction compared to beta-blockers and diuretics.
- Antihypertensive therapy, including these agents, significantly reduces cardiovascular morbidity and mortality in elderly patients.
Impact:
- Provides evidence-based recommendations for optimal hypertension treatment strategies.
- Highlights the benefits of specific drug combinations for improved patient outcomes and reduced healthcare burden.
Related Concept Videos
Hypertension III: Clinical Manifestations and Diagnostic Studies
Hypertension II: Pathophysiology
Hypertension IV: Drug Therapy and Lifestyle Modifications
Hypertension and Regulation of Blood Pressure
Hypertension I: Introduction
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System